Select status:
Sort by:
Filter by last updated date

Please enter a valid month/year e.g. 01/2015

Pick a date between August 2020 and February 2021

Filter by area of interest
Filter by type
Showing 1 to 10 of 148
Title Reference number Published Last updated
Safeguarding adults in care homes Reference number:NG189 NG00189 Published:26 February 2021 20210226 Last updated:26 February 2021 20210226
Remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn’s disease and ulcerative colitis Reference number:ES35 ES00035 Published:24 February 2021 20210224 Last updated:24 February 2021 20210224
Metreleptin for treating lipodystrophy Reference number:HST14 HST00014 Published:24 February 2021 20210224 Last updated:24 February 2021 20210224
Filgotinib for treating moderate to severe rheumatoid arthritis Reference number:TA676 TA00676 Published:24 February 2021 20210224 Last updated:24 February 2021 20210224
Autologous anti-CD19-transduced CD3+ cells for treating relapsed or refractory mantle cell lymphoma Reference number:TA677 TA00677 Published:24 February 2021 20210224 Last updated:24 February 2021 20210224
Omalizumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal) Reference number:TA678 TA00678 Published:24 February 2021 20210224 Last updated:24 February 2021 20210224
Dapagliflozin for treating chronic heart failure with reduced ejection fraction Reference number:TA679 TA00679 Published:24 February 2021 20210224 Last updated:24 February 2021 20210224
COVID-19 rapid evidence summary: Tocilizumab for COVID-19 Reference number:ES33 ES00033 Published:15 January 2021 20210115 Last updated:24 February 2021 20210224
Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy Reference number:TA673 TA00673 Published:17 February 2021 20210217 Last updated:17 February 2021 20210217
Pembrolizumab for untreated PD-L1-positive, locally advanced or metastatic urothelial cancer when cisplatin is unsuitable (terminated appraisal) Reference number:TA674 TA00674 Published:17 February 2021 20210217 Last updated:17 February 2021 20210217